616.234.5000
Phase II colorectal cancer
clinical trial first to receive
support, scientific oversight from
VARI-SU2C
Epigenetics Dream Team
Learn More

Van Andel Research Institute and Stand Up To Cancer continue Epigenetics Dream Team

Learn More

VARI-SU2C Epigenetics Dream Team

Stephen Baylin, M.D.
The Van Andel Research Institute-Stand Up to Cancer (VARI-SU2C) Epigenetics Dream Team is a multi-institutional effort to develop new epigenetic therapies to combat cancer, and to move promising therapies to clinical trials.

Learn More